整合AIPSS-MF与分子预测指标：骨髓纤维化预后模型的比较分析 - Suppr

Integrating AIPSS-MF and molecular predictors: A comparative analysis of prognostic models for myelofibrosis.

作者信息

Mosquera-Orgueira Adrián, Arellano-Rodrigo Eduardo, Garrote Marta, Martín Iván, Pérez-Encinas Manuel, Gómez-Casares María-Teresa, Hernández-Sánchez Alberto, Ferrer-Marín Francisca, Mora Elvira, Velez Patricia, Ayala Rosa, Angona Anna, Heras Natalia de Las, Magro Elena, Pérez-Míguez Carlos, Crucitti Davide, Mata-Vázquez María-Isabel, Fox María-Laura, González de Villambrosía Sonia, Ramírez María-José, García Ana, García-Gutiérrez Valentín, Cáceres Amparo, Durán María-Antonia, Senín María-Alicia, Raya José-María, González José A, Cuevas Beatriz, Xicoy Blanca, Nangalia Jyoti, Hernández-Rivas Jesús M, Bellosillo Beatriz, Álvarez-Larrán Alberto, Hernández-Boluda Juan C

机构信息

Santiago de Compostela Hospital Clínico Universitario Valencia Spain.

Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer Barcelona Spain.

出版信息

Hemasphere. 2024 Mar 20;8(3):e60. doi: 10.1002/hem3.60. eCollection 2024 Mar.

DOI:10.1002/hem3.60

PMID:38510992

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10951878/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd0c/10951878/57280b2986b3/HEM3-8-e60-g001.jpg

相似文献

Integrating AIPSS-MF and molecular predictors: A comparative analysis of prognostic models for myelofibrosis.整合AIPSS-MF与分子预测指标：骨髓纤维化预后模型的比较分析

Hemasphere. 2024 Mar 20;8(3):e60. doi: 10.1002/hem3.60. eCollection 2024 Mar.

AIPSS-MF machine learning prognostic score validation in a cohort of myelofibrosis patients treated with ruxolitinib.AIPSS-MF 机器学习预后评分在接受鲁索利替尼治疗的骨髓纤维化患者队列中的验证。

Cancer Rep (Hoboken). 2023 Oct;6(10):e1881. doi: 10.1002/cnr2.1881. Epub 2023 Aug 8.

Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of Myelofibrosis.机器学习改善骨髓纤维化的风险分层：西班牙骨髓纤维化登记处的分析

Hemasphere. 2022 Dec 20;7(1):e818. doi: 10.1097/HS9.0000000000000818. eCollection 2023 Jan.

[Analysis of prognostic factors in Chinese patients with post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis].真性红细胞增多症后骨髓纤维化和原发性血小板增多症后骨髓纤维化中国患者的预后因素分析

Zhonghua Xue Ye Xue Za Zhi. 2016 Oct 14;37(10):876-880. doi: 10.3760/cma.j.issn.0253-2727.2016.10.012.

Cancer. 2022 Oct 1;128(19):3495-3501. doi: 10.1002/cncr.34414. Epub 2022 Aug 9.

Differences in presenting features, outcome and prognostic models in patients with primary myelofibrosis and post-polycythemia vera and/or post-essential thrombocythemia myelofibrosis treated with ruxolitinib. New perspective of the MYSEC-PM in a large multicenter study.原发性骨髓纤维化和真性红细胞增多症后/或原发性血小板增多症后骨髓纤维化患者接受芦可替尼治疗的临床表现、结局和预后模型的差异。一项大型多中心研究中 MYSEC-PM 的新视角。

Semin Hematol. 2018 Oct;55(4):248-255. doi: 10.1053/j.seminhematol.2018.05.013. Epub 2018 Jun 5.

Patients with post-essential thrombocythemia and post-polycythemia vera differ from patients with primary myelofibrosis.原发性血小板增多症后和真性红细胞增多症后的患者与原发性骨髓纤维化患者有所不同。

Leuk Res. 2017 Aug;59:110-116. doi: 10.1016/j.leukres.2017.06.001. Epub 2017 Jun 2.

The European Consensus on grading of bone marrow fibrosis allows a better prognostication of patients with primary myelofibrosis.欧洲骨髓纤维化分级共识有助于更好地预测原发性骨髓纤维化患者的预后。

Mod Pathol. 2012 Sep;25(9):1193-202. doi: 10.1038/modpathol.2012.87. Epub 2012 May 25.

The evolving understanding of prognosis in post-essential thrombocythemia myelofibrosis and post-polycythemia vera myelofibrosis vs primary myelofibrosis.真性红细胞增多症后骨髓纤维化和原发性血小板增多症后骨髓纤维化与原发性骨髓纤维化的预后的逐步认识。

Clin Adv Hematol Oncol. 2019 May;17(5):299-307.

Clinicopathologic features and prognostic indicators in Chinese patients with myelofibrosis.中国骨髓纤维化患者的临床病理特征及预后指标

Hematology. 2016 Jan;21(1):10-8. doi: 10.1179/1607845415Y.0000000045. Epub 2015 Aug 20.

引用本文的文献

Prognostic and Predictive Models in Myelofibrosis.骨髓纤维化的预后和预测模型。

Curr Hematol Malig Rep. 2024 Oct;19(5):223-235. doi: 10.1007/s11899-024-00739-6. Epub 2024 Aug 24.

本文引用的文献

Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: updated recommendations by the EBMT/ELN International Working Group.骨髓纤维化异基因造血干细胞移植的适应证和处理：EBMT/ELN 国际工作组的更新建议。

Lancet Haematol. 2024 Jan;11(1):e62-e74. doi: 10.1016/S2352-3026(23)00305-8. Epub 2023 Dec 4.

Cancer Rep (Hoboken). 2023 Oct;6(10):e1881. doi: 10.1002/cnr2.1881. Epub 2023 Aug 8.

Impact of TP53 on outcome of patients with myelofibrosis undergoing hematopoietic stem cell transplantation.TP53 对接受造血干细胞移植的骨髓纤维化患者结局的影响。

Blood. 2023 Jun 8;141(23):2901-2911. doi: 10.1182/blood.2023019630.

Hemasphere. 2022 Dec 20;7(1):e818. doi: 10.1097/HS9.0000000000000818. eCollection 2023 Jan.

Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study.原发性和继发性骨髓纤维化的基因组分析重新定义了 ASXL1 突变的预后影响：FIM 研究。

Blood Adv. 2021 Mar 9;5(5):1442-1451. doi: 10.1182/bloodadvances.2020003444.

Prognostic impact of RAS-pathway mutations in patients with myelofibrosis.RAS 通路突变对骨髓纤维化患者预后的影响。

Leukemia. 2020 Mar;34(3):799-810. doi: 10.1038/s41375-019-0603-9. Epub 2019 Oct 18.

Classification and Personalized Prognosis in Myeloproliferative Neoplasms.骨髓增殖性肿瘤的分类与个体化预后

N Engl J Med. 2018 Oct 11;379(15):1416-1430. doi: 10.1056/NEJMoa1716614.

GIPSS: genetically inspired prognostic scoring system for primary myelofibrosis.GIPSS：原发性骨髓纤维化的基因启发预后评分系统。

Leukemia. 2018 Jul;32(7):1631-1642. doi: 10.1038/s41375-018-0107-z. Epub 2018 Mar 23.

Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet.费城染色体阴性经典骨髓增殖性肿瘤：欧洲白血病网的修订管理建议。

Leukemia. 2018 May;32(5):1057-1069. doi: 10.1038/s41375-018-0077-1. Epub 2018 Feb 27.

MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis.MIPSS70：原发性骨髓纤维化移植年龄患者的突变增强国际预后评分系统。

J Clin Oncol. 2018 Feb 1;36(4):310-318. doi: 10.1200/JCO.2017.76.4886. Epub 2017 Dec 9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Integrating AIPSS-MF and molecular predictors: A comparative analysis of prognostic models for myelofibrosis.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献